Search research articles
Contact Us
Filters
Showing results (231-240 of 292) with videos related to
Page
of 30
Sort By:
Journal for Immunotherapy of Cancer
|
June 7, 2018
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
Edwin R Parra, Pamela Villalobos, Carmen Behrens, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 17, 2017
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series
A Iorio, A M Barbara, M Makris, et al.
Cancer Research
|
May 18, 2021
The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells
Prashant V Bommi, Charles M Bowen, Laura Reyes-Uribe, et al.
Immunobiology
|
August 31, 2014
The Th17 pathway in the peripheral lung microenvironment interacts with expression of collagen V in the late state of experimental pulmonary fibrosis
Alexandre T Fabro, Pedro H R Q da Silva, William S Zocolaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network
Guray Akturk, Edwin R Parra, Evisa Gjini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2019
Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer
Y Kudo, C Haymaker, J Zhang, et al.
Blood Advances
|
March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
Mario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Journal for Immunotherapy of Cancer
|
May 1, 2020
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort
Kyle G Mitchell, Lixia Diao, Tatiana Karpinets, et al.
Cancer
|
January 4, 2023
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort
William N William, Jianjun Zhang, Xin Zhao, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2022
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 292) with videos related to
Sort By:
Page
of 30
Journal for Immunotherapy of Cancer
|
June 7, 2018
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
Edwin R Parra, Pamela Villalobos, Carmen Behrens, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 17, 2017
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series
A Iorio, A M Barbara, M Makris, et al.
Cancer Research
|
May 18, 2021
The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells
Prashant V Bommi, Charles M Bowen, Laura Reyes-Uribe, et al.
Immunobiology
|
August 31, 2014
The Th17 pathway in the peripheral lung microenvironment interacts with expression of collagen V in the late state of experimental pulmonary fibrosis
Alexandre T Fabro, Pedro H R Q da Silva, William S Zocolaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network
Guray Akturk, Edwin R Parra, Evisa Gjini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2019
Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer
Y Kudo, C Haymaker, J Zhang, et al.
Blood Advances
|
March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
Mario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Journal for Immunotherapy of Cancer
|
May 1, 2020
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort
Kyle G Mitchell, Lixia Diao, Tatiana Karpinets, et al.
Cancer
|
January 4, 2023
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort
William N William, Jianjun Zhang, Xin Zhao, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2022
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.
Page
of 30